Clinically relevant measures of fit? A note of caution (Q36489222)

14 August 2017

Clinically relevant measures of fit? A note of caution (English)

1 reference

14 August 2017

Nancy R Cook

1

1 reference

PMCID

3530355

14 August 2017

language of work or name

English

0 references

publication date

8 August 2012

1 reference

American Journal of Epidemiology

14 August 2017

1 reference

14 August 2017

176

1 reference

14 August 2017

6

1 reference

14 August 2017

488-491

1 reference

Interpreting incremental value of markers added to risk prediction models

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Commentary: Reporting standards are needed for evaluations of risk reclassification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Performance of reclassification statistics in comparing risk prediction models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

One statistical test is sufficient for assessing new predictive markers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Use and misuse of the receiver operating characteristic curve in risk prediction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Therapeutic Decision Making: A Cost-Benefit Analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Risk stratification after acute myocardial infarction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530355

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22875759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comments on 'Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers' by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22875759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/AJE/KWS208

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3530355